Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
    • 7 Principles
Login
  • Donate
0

Press Releases

MAPS Wins Appeal and Authorization to Study MDMA in Healthy Volunteer Therapists

Phase 1 clinical trials of MDMA-assisted therapy for healthcare providers will measure development of self-compassion, professional quality of life, and professional burnout among clinicians delivering …
May 12, 2021

MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD

The highly statistically significant results and excellent safety record suggest MDMA-assisted therapy will be approved as effective treatment for severe, chronic PTSD in 2023. 67% of participants who …
May 3, 2021

First Controlled Trial of Cannabis for the Treatment of PTSD Raises No Safety Concerns, Further Research is Needed to Determine Efficacy

Widespread anecdotal reports of benefit have led to self-treatment of the symptoms of PTSD with cannabis among Veterans and others; the safety and potential efficacy of such treatments have not previously …
March 17, 2021

Statement: California State Legislator Introduces Bill to Decriminalize Psychedelics

CA State Senator Scott Wiener introduced Senate Bill 519 to decriminalize certain psychedelics in the interest of public health and safety and to address some harms of the War on Drugs. The bill would …
February 18, 2021

MAPS and Fireside Project Announce Collaboration to Expand Access to Psychedelic Peer Support

MAPS and Fireside Project announced a collaboration that will be recognized as a major step forward in creating a safer, more thriving psychedelic movement. As medicine and mental healthcare begin to embrace …
February 7, 2021

MAPS Public Benefit Corporation Expands Talent with Three Leadership Hires

MAPS PBC, a wholly-owned subsidiary of MAPS,has recently expanded their team with three new leaders bringing decades of experience relevant to the MAPS PBC mission: catalyzing healing and well-being through …
January 26, 2021

MAPS-Sponsored Pilot Study: MDMA-Assisted Therapy for PTSD in Couples May Reduce PTSD Symptoms, Improve Couples’ Happiness

FOR IMMEDIATE RELEASEDecember 7, 2020 Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD), when combined with MDMA, resulted in significant improvements in PTSD symptoms …
December 7, 2020

Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval

On the heels of United Nations’ Commission on Narcotic Drugs removal of medical marijuana from the list of most dangerous drugs, lawsuit demands processing and approval of licenses to support research …
December 3, 2020

Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval

On the heels of United Nations’ Commission on Narcotic Drugs removal of medical marijuana from the list of most dangerous drugs, lawsuit demands processing and approval of licenses to support research …
December 3, 2020

Study: MDMA-Assisted Therapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness

Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness. The primary outcome, change …
November 24, 2020

Statement from the Multidisciplinary Association for Psychedelic Studies on Drug Policy Reform in the 2020 U.S. Election

Following the passage of all nine statewide ballot measures to reform drug policies across the United States, including the first measure to decriminalize drug possession in Oregon with a Portugal-inspired …
November 4, 2020

Study: MDMA-Assisted Therapy Will Be Cost-Effective in the Treatment of PTSD

A peer-reviewed study published today in the research journal PLOS ONE demonstrates that MDMA-assisted psychotherapy is cost-effective in the treatment of posttraumatic stress disorder (PTSD). It is estimated …
October 14, 2020

Posts navigation

Newer Posts Page 1 … Page 4 … Page 10 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Proudly powered by WordPress. Hosted by Pressable.